CN1079002A - Chicken growth hormone gene and the expression in intestinal bacteria thereof - Google Patents
Chicken growth hormone gene and the expression in intestinal bacteria thereof Download PDFInfo
- Publication number
- CN1079002A CN1079002A CN 93102099 CN93102099A CN1079002A CN 1079002 A CN1079002 A CN 1079002A CN 93102099 CN93102099 CN 93102099 CN 93102099 A CN93102099 A CN 93102099A CN 1079002 A CN1079002 A CN 1079002A
- Authority
- CN
- China
- Prior art keywords
- cgh
- growth hormone
- intestinal bacteria
- chicken growth
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000824878 Gallus gallus Somatotropin Proteins 0.000 title claims abstract description 88
- 241000894006 Bacteria Species 0.000 title claims abstract description 40
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 37
- 241000588724 Escherichia coli Species 0.000 claims abstract description 18
- 239000013604 expression vector Substances 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 210000003000 inclusion body Anatomy 0.000 claims description 15
- 238000013016 damping Methods 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- 230000002068 genetic effect Effects 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 4
- 238000005571 anion exchange chromatography Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims description 2
- 239000003637 basic solution Substances 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims 2
- 229920005989 resin Polymers 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 229920004890 Triton X-100 Polymers 0.000 claims 1
- 239000013504 Triton X-100 Substances 0.000 claims 1
- 239000003957 anion exchange resin Substances 0.000 claims 1
- -1 diethylaminoethyl- Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 25
- 108090000623 proteins and genes Proteins 0.000 abstract description 18
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000005556 hormone Substances 0.000 abstract description 6
- 229940088597 hormone Drugs 0.000 abstract description 6
- 241000287828 Gallus gallus Species 0.000 abstract description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 108091008146 restriction endonucleases Proteins 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000012634 fragment Substances 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 11
- 125000003729 nucleotide group Chemical group 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 9
- PLVPPLCLBIEYEA-WAYWQWQTSA-N (z)-3-(1h-indol-3-yl)prop-2-enoic acid Chemical compound C1=CC=C2C(\C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-WAYWQWQTSA-N 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 8
- PLVPPLCLBIEYEA-UHFFFAOYSA-N indoleacrylic acid Natural products C1=CC=C2C(C=CC(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-UHFFFAOYSA-N 0.000 description 8
- 239000011535 reaction buffer Substances 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 102000003960 Ligases Human genes 0.000 description 5
- 108090000364 Ligases Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000000122 growth hormone Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 102000018997 Growth Hormone Human genes 0.000 description 4
- 108010051696 Growth Hormone Proteins 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical group CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100495531 Caenorhabditis elegans cgh-1 gene Proteins 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 101150041787 IAA5 gene Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- UMSVPCYSAUKCAZ-UHFFFAOYSA-N propane;hydrochloride Chemical compound Cl.CCC UMSVPCYSAUKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940055835 triptone Drugs 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to the purifying of the chicken growth hormone of chicken growth hormone gene and its expression method and expression, the CGH gene that has particularly related to energy scale operation hormone in intestinal bacteria, with the colibacillary method of described expression vector conversion, and the method for producing the method for chicken production hormone and the chicken production hormone that the purifying Bacillus coli cells is produced with the intestinal bacteria transformant.
Description
The present invention relates to the purifying of the chicken growth hormone of a chicken growth hormone gene and its expression and expression.Be meant that more specifically the present invention relates to one is used in the chicken growth hormone gene that carries out the mass production chicken growth hormone in the intestinal bacteria, with this gene constructed expression vector, the Bacillus coli cells that transforms with this expression vector, and produce the method for chicken growth hormone and purifying is produced chicken production hormone by intestinal bacteria method with this intestinal bacteria transformant.
Up to the present, in cattle breeding, improved efficiency of feed utilization greatly and made the domestic animal weight increase by in conventional feed, sneaking into high protein material or steroid hormone, yet, the source of high protein material is limited, use steroid hormone because it is residual over a long time in animal body, may produce certain side effect to human body, thereby controlled by strictness.
By contrast, the animal growth hormone that has been developed in the recent period is but in animal body not residual, and has specificity, and it is harmless therefore being considered to the mankind.In view of the above, animal growth hormone is considered to promoting that aspect the fast growth of animal be a kind of desirable material.
Animal growth hormone is a kind of sub-thread chain sphaeroprotein, approximately form (referring to Barrinton etc. by 190 to 200 amino acid, Academic Press, N.Y., 2(1979)), thus it is participate in to regulate lipid and carbohydrate and protein metabolism to promote one of some protein hormone of animal tissues's growth.
At the tethelin that the animal brain prepituitary gland produces is ripe and get from the tethelin precursor that contains segment signal order at aminoterminal.The tethelin precursor just becomes sophisticated functional growing hormone (Davies etc., Nature 283,433-438(1980)) through cutting a segment signal sequence when by endoplasmic reticulum.
Tethelin stimulates translating of mRNA simultaneously by promoting that amino acid enters the balanced growth of accelerating animal in the cell, impels the division growth of cell, and this is an important factors for growth.Thereby the animal of injection tethelin is not increasing forage volume when improving the means of tissue protein, and it is fast that body weight is still carried nice and high.
The complete sequence amino-acid sequence of present most of animal growth hormones determined, some animal growth hormone genes clone and expressing in intestinal bacteria is also arranged, for example people, ox, pig and rat (Miller etc., JBC 255,7521-7524; Martial etc., Science 205,602-607(1979); Seeburg etc., Nature 270,486-494(1977)).Method that up to the present still can not using gene engineering is produced chicken growth hormone on a large scale in intestinal bacteria.
The chicken growth hormone of producing in the intestinal bacteria transformant usually forms an inclusion body, thereby its solubilization of inclusion bodies could should be isolated chicken growth hormone from the intestinal bacteria transformant.Yet known have several dissolving methods, for example, use urea, guanidinesalt or sodium lauryl sulphate (Sodium dodecylsulfate) etc., but they all have some defective relevant with following factor, and as purifying expense height, purge process is too complicated and yield poorly etc.
In addition, also have some purification process, for example, the monoclonal antibody affinity chromatography method (B.Houston etc., J.Endocr.125,207-215(1990)) and the combined utilization (L.M.Souza etc. of negatively charged ion, cation-exchange chromatography, J.Exp.Zoology, 232,465-474(1984))., the monoclonal antibody affinity chromatography method is not suitable for large scale purification because of manufacture order clonal antibody cost is very high.The method high complexity of Souza, the problem that will remove the heat source substance of Escherichia coli source in addition.
The purpose of this invention is to provide one and be designed to effective expression and the chicken growth hormone gene that can be used for scale operation chicken growth hormone (CGH) in intestinal bacteria.
Another object of the present invention provides a kind of Bacillus coli cells that contains said CGH expression carrier and transform with this carrier.
Further purpose of the present invention provides a kind of method of producing CGH with the intestinal bacteria transformant.
Another object of the present invention provides the method for the CGH that a kind of effective separation and purifying produce on the intestinal bacteria transformant, mainly adopted in the method with alkali reagent and be dissolved in the CGH inclusion body that produces in the Bacillus coli cells.
Correspondingly, with one aspect of the present invention be the nucleotide sequence that shows the CGH gene at Fig. 1, this sequence is designed in intestinal bacteria to produce ripe CGH.
Another aspect of the present invention provides a Bacillus coli cells that contains described CGH expression carrier and transform with this carrier.
A further aspect of the invention provides a method of producing CGH on the intestinal bacteria transformant, and this mainly is to cultivate the intestinal bacteria transformant under the culture condition of CGH gene and obtain CGH being fit to express.
For another aspect of the present invention provides the method for a kind of purifying CGH, it comprises: separatin non-soluble inclusion body from the intestinal bacteria transformant of producing chicken growth hormone; Wash insoluble inclusion body with the solution that contains tensio-active agent and ethylenediamine tetraacetic acid (EDTA) (EDTA), then, further with damping fluid that contains NaCl or distillation washing; The inclusion body that suspension had been washed in a kind of basic solution is collected at dissolving forgives intravital CGH; Centrifugal this suspension is collected supernatant liquor, carries out ultrafiltration, promptly contains dissolved CGH in the filtrate; Analyse post by a cation exchange resin layer again.
CGH gene of the present invention is to be that basic design is come out with (J.of Exp.Zoology 232,465-473(1984)) described aminoacid sequences such as L.M.Souza, and is specific as follows:
(ⅰ) before the-terminal amino acid Threonine password of ripe CGH, put into the initiation codon of a methionine(Met).
(ⅱ) behind the password of the C-of ripe CGH end amino acid Isoleucine, put into two termination codon TAG and TAA so that stop at the Isoleucine place when translating.
(ⅲ) recognition site of several restriction enzymes is introduced into this gene so that make this gene of modification convenient, and these sites are: SacI(5 '-GAGCTC-3 ', contain the arginic password of the 17th amino acids), EcoRI(5 '-GAATTC-3 '; The password that contains the 31st amino acids L-glutamic acid), the Bal II (5 '-GAGTCT-3 '; The password that contains the 115th amino acids aspartic acid) and the Hind III (5 '-AAGCTT-3 '; The password that contains the 121st amino acids glutamine); And,
(ⅳ) can form the nucleotide sequence of secondary structure or subsequence and be modified, being expressed in of CGH transcribed and the level of translating reaches optimum regime by substituting some Nucleotide.
The complete nucleotide sequence of CGH gene can as with dna synthesizer or polymerase chain reaction (PCR), be synthesized into by known ordinary method.
The present invention is used for can adapting to colibacillary various expression system by use in the described CGH expression carrier of escherichia coli expression and prepares.
For example, can use the ptrp322H-HGH carrier to prepare, this carrier has description (the host cell intestinal bacteria W3110 that contains described ptrp322H-HGH carrier has been preserved in Korea S microbial strains preservation center, and code name is KFCC-10667) in Korea S publication publication No.91-457.Be exactly specifically this preparing carriers be to be used in the CGH gene shown in Fig. 1 to replace human growth hormone gene in ptrp322H-HGH, this will be described in the embodiment of back.
The CGH expression carrier that contains of Huo Deing is named as ptrp-CST like this.The intestinal bacteria W3110(ATCC 27325 of Zhuan Huaing thus) is deposited in Korea S microbial strains preservation center for the patented procedure purpose on June 26th, 1991 by international microbial preservation budapest treaty, is numbered KCCM-10005.
Cultivate under the condition that can make CGH genetic expression with the Bacillus coli cells that contains the conversion of CGH expression carrier, further determine by the feature of carrier and intestinal bacteria recipient cell.
For example, in containing the M9 substratum of penbritin, cultivate,, add indole acrylic acid and continue to cultivate when optical density value (OD) under 650nm when reaching 0.5 with the intestinal bacteria W3110 cell that the ptrp-CST expression vector transforms.
The CGH that produces in the intestinal bacteria transformant can separate and purifying by series of steps, and these steps comprise cell rupture, centrifugal, dissolving, transfer pH to alkalescence, filter and chromatography.
Specifically be exactly to carry out ultrasonic again with smudge cells by in cultured cell, adding N,O-Diacetylmuramidase.Broken cell centrifugation precipitation is collected the throw out that contains the CGH inclusion body.
This throw out is washed once with containing with tensio-active agent (as: 0.1%-1% Triton (Triton) X-100) and the damping fluid of EDTA, then, uses another damping fluid again instead and (as: contains 100-500mM NaCl or NH
4The pH7.2 solution of Cl) or distillation washing to remove cytolemma and other foreign protein.The CGH inclusion body of Huo Deing is suspended in the distilled water again like this, slowly adds alkaline solution (NaOH or KOH solution) then, the limit edged stirs, and pH is adjusted between 11.5 to 13.0, is preferably 11.8 to 12.3.This suspension is further centrifugal to remove insoluble impurities.The supernatant suspension obtains to contain the solution of solubility CGH with ultra-filtration filters, transfers between the filtrate pH to 8.5 and 10.5, is preferably 9.0 to 9.5.Joining the anion-exchange chromatography post through adjusted filtrate, be preferably the DEAE(diethylaminoethylcellulose) to carry out chromatography be high-purity CGH 95% or more and the intracellular toxin that is lower than 10 units/milligram concentration to obtain purity to post.
The present invention has overcome the deficiency of CGH production method in the prior art, has obtained a kind of chicken growth hormone of high purity low endotoxin content.
The following examples will specify content of the present invention in being not limited to scope of the present invention.The test method of Shi Yonging should be undertaken by the content that reference example is given if not otherwise specified in an embodiment.
Brief Description Of Drawings is as follows:
Fig. 1 shows CGH gene nucleotide series of the present invention and the aminoacid sequence of deriving thus;
Fig. 2 has described the scheme that obtains CGH gene shown in Figure 1.
Fig. 3 has shown to make up to contain and has been useful on the expression carrier at expression in escherichia coli CGH.
Fig. 4 is presented at the intestinal bacteria transformant SDS-PAGE(sodium dodecyl sulfate-polyacrylamide gel electrophoresis of cultivating under the condition that is fit to CGH genetic expression) the result.
Fig. 5 provides in the intestinal bacteria of cultivating the SDS-PAGE result of CGH behind the purifying under being fit to CGH genetic expression condition.
Fig. 6 has disclosed the HPLC(of purifying CGH from effect liquid phase chromatogram) the result.
Unless the solid composition in the solid mixture of mentioning especially otherwise occurring in following, liquid composition in the solution and the solid composition in the liquid are respectively with w/w (wt/wt), and volume/volume (vol/vol) and weight/volume (wt/vol) are the basis.
Reference example 1: restriction endonuclease dna digestion
Restriction endonuclease used herein and reaction buffer be all available from NEB(New England Biolabs, Jolla, and MA, U.S.A.).
This reaction is carried out in the Eppendorf of sterilization pipe usually, reaction volume is at 50 μ l-100 μ l, 37 ℃ of reactions 1-24 hour, afterwards, this reaction mixture carries out thermal treatment in 15 minutes (or with phenol extracting, ethanol sedimentation to prevent the effect of heat resistance restriction endonuclease) at 65 ℃ and is used for the deactivation restriction endonuclease.
The 10X reaction buffer that is used for the restriction endonuclease reaction is made up of following:
10X NEB reaction buffer 1:100mM double Tris pronane hydrochloric acid (bis Tris propane-HCl), 100mM magnesium chloride (MgCl
2), the 10mM dithiothreitol (DTT) (dithiothreitol, DTT), pH7.0;
10X NEB reaction buffer 2:100mM Tris-HCl, 100mM MgCl
2, 500mM NaCl, 10mM DTT, pH7.0;
10X NEB reaction buffer 3:100mM Tris-HCl, 100mM MgCl
2, 1000mM NaCl, 10mM DTT, pH7.0;
10X NEB reaction buffer 4:200mM Tris-acetate, 100mM magnesium acetate, 500mM potassium acetate, 10mM DTT, pH7.0.
Reference example 2: phenol extracting and ethanol sedimentation
After finishing enzyme reaction, reaction mixture phenol extracting its objective is the effect of wanting the deactivation restriction endonuclease and obtains DNA in the reaction mixture.Here it is to be noted that the phenol that uses needs in advance with containing 10mM Tris-HCl(pH8.0) and 10mM EDTA(ethylenediamine tetraacetic acid (EDTA)) the damping fluid balance.The phenol extractive process is pressed the step and is carried out: mix isopyknic phenol solution and sample liquid, concuss; With 15000rpm centrifugal mixture 5 minutes; Again water is changed in the new pipe, repeat said process 2-3 time.
Then, with equal-volume chloroformic solution (chloroform: extracting water isopropylcarbinol=24: 1), isolate water again, the 3M sodium acetate solution and 2.5 volume of ethanol that inwardly add 0.1 volume, put-70 ℃ of stops 30 minutes or stopped 12 hours so that nucleic acid is separated out at-20 ℃, afterwards, at 4 ℃, with 15000 rpm centrifugal mixtures 20 minutes, collecting precipitation.
Reference example 3: ligation
The DNA ligation is the T that uses available from NEB
4(pH 7.8,0.5M Tris-HCl, 0.1M MgCl for ligase enzyme and 10X ligase enzyme damping fluid
2, 0.2M DTT, 10mM ATP, 0.5mg/ml bovine serum albumin (BSA)) carry out.Reaction volume is generally 20 μ l, the T of 10 units
4Ligase enzyme is used to connect the sticky end of DNA, and 100 units are used to connect the DNA of blunt end.
Being reflected at 16 ℃ carries out carrying out more than 14 hours in 5 hours or 4 ℃.After reaction finished, this reaction mixture heated 15 minutes with deactivation T at 65 ℃
4Dna ligase.
Reference example 4: colibacillary conversion
The coli strain that uses among the following embodiment comprises intestinal bacteria HB101(ATCC 33694): intestinal bacteria W 3110(ATCC 27325) and intestinal bacteria JM105(ATCC 47016).A kind of method well known in the art has been used in colibacillary conversion, promptly at Maniatis etc., Molecular Cloning:A Laboratory Manual, Cold Spring Harbor Press, N.Y.(1982) or Cohen, Proc.Natl.Acad.Sci.U.S.A., 69, the method for the transformed into escherichia coli of being introduced on 2110(1972).
Reference example 5: oligonucleotide fragment synthetic
The synthetic of oligonucleotide fragment is with an automatic solid phase phosphamidon chemical method (automatic solid phase phosphoamidite chemistry) dna synthesizer (Applied Biosystems Inc., 3808, U.S.A.) finish.
Synthetic oligonucleotide denaturing polyacrylamide gel (2M urea, 12% acrylamide and two fork acrylamide (29: 1), 50mM Tris, 50mM boric acid, 1mM EDTA) electrophoresis and SEP-PAK(Waters Inc., U.S.A.) column chromatography carries out purifying, determines its content by measure optical density(OD) (O.D.) value at the 260nm place.
Reference example 6: polymerase chain reaction (PCR)
Give and add following material: 10 μ l 10X Taq polymeric enzyme reaction damping fluid (10mM Tris-HCl, 500mM KCl, 15mM MgCl in the template DNA mixture of 10-100ng
20.1%(w/v) gelatin, pH8.3), 10 μ l dNTP ' s mixtures (at each 1.25mM of dGTP, dATP, dTTP and dCTP), 2 each primer of μ g are (usually, 2 kinds of primers are used in reaction, in case use 4 kinds of primers, being positioned at intermediary primer usage quantity is 0.02 μ g) and 0.5 μ l Ampli Taq archaeal dna polymerase (Perkin Elmer Cetus, U.S.A.), transferring to cumulative volume with distilled water is 100 μ l, adds 50 μ l mineral oil again to prevent the hybrid reaction evaporation.
PCR is that (Perkin Elmer Cetus carries out in U.S.A), suitably repeats repeatedly by the thermal cycling program, and circular order is: ℃ 30 second → 72,95 ℃ of 30 second → 55 ℃ 1 minute at a thermal cycler; Last circulation time is reflected at 72 ℃ and carried out 10 minutes.
After reaction is finished, mixture phenol extracting, the PCR product goes out with ethanol sedimentation, this throw out is dissolved in the 20 μ l TE damping fluids (10mM Tris-HCl, 1mM EDTA pH7.5) again.
Embodiment 1: the preparation of chicken growth hormone gene
(1-A): the design of the oligonucleotide of structure CGH gene and synthetic
For prepare to be contained in 5 '-recognition site of the restricted property restriction endonuclease Nde I recognition site of end and 2 termination codons and restriction enzyme Sal I, describe with reference example 5
Oligonucleotide CGH1 5 '-end contains the recognition site of a restriction enzyme Nde I: 5 '-CATATG-3 ' and 3 '-end has 5 of 20 nucleotide residues and CGH2 '-end complementation.
5 of CGH3 '-end has 20 nucleotide residues and CGH4 3 '-end complementation, 5 of CGH5 '-end has 3 of 20 nucleotide residues and CGH6 '-end complementary, 5 of CGH7 '-end has 3 of 20 nucleotide residues and CGH8 '-end complementary, and 5 of CGH9 '-end has 3 of 20 nucleotide residues and CGH10 '-end complementary.
(1-B): the preparation of full CGH gene
<the first step 〉
Carry out the following PCR reaction first time by reference example 6: give to add 2 μ g CGH1,0.02 μ g CGH2,0.02 μ g CGH3 and 2 μ g CGH4 among the reaction tubes A; Give and add 2 μ g CGH5,0.02 μ g CGH6,0.02 μ g CGH7 and 2 μ g CGH8 among the reaction tubes B; Give and add 2 μ g CGH9 and 2 μ g CGH10 among the reaction tubes C.Give again respectively and add 10 μ l 10X Taq polymerase buffer (100mM Tris-HCl, pH8.3,500mM KCl, 15mM MgCl in above-mentioned 3 pipes
2, 0.1%(w/v) gelatin), 10 μ l dNTP ' s mixtures (dGTP, dATP, dTTP, each 1.25mM of dCTP), 0.5 μ l(5 unit/μ l) Ampli Taq archaeal dna polymerase and 67 μ l distilled water.Thermal cycling is in proper order: ℃ 30 second → 72,95 ℃ of 30 second → 55 ℃ 1 minute, repeat this order 4 times after, should be further after this carry out in 10 minutes at 72 ℃.Last reaction mixture application of sample carries out electrophoretic separation in polyacrylamide gel and goes out PCR product for the first time.This product is further used Elutip-D(Schleicher ﹠amp; Schuell, U.S.A.) purifying is dissolved in the 20 μ l TE damping fluids (10mM Tris-HCl, pH7.5,1mM EDTA).
<the 2 step 〉
With the 1st PCR product by following the 2nd polymerase chain reaction (PCR) process of carrying out.
About 100ng PCR product in reaction tubes A is blended among the reaction tubes D with the about 100ng PCR product in reaction tubes B, add 2 μ gCGH1 again, 2 μ g CGH8,10 μ l 10X Taq polymerase buffers, 10 μ l dNTP ' s mixtures, 0.5 μ l(5 unit/μ l) Ampli Taq archaeal dna polymerase and 67 μ l distilled water.This mixture carries out 20 PCR circulations.The PCR product of Huo Deing is by<the 1 step like this〉identical method processing, at last product is dissolved among the 20 μ l TE damping fluids.
<the 3 step 〉
Press with the 2nd PCR product and to give an account of the program that continues and carry out the 3rd PCR reaction.
Each reactant below in reaction tubes E, adding: the PCR product among the product of the PCR among about 100ng reaction tubes D, the about 100ng reaction tubes C, 2 μ g CGH1,2 μ gCGH10,10 μ l 10X Taq polymerase buffers, 10 μ l dNTP ' s mixtures, 0.5 μ l(5 unit/μ l) Ampli Taq archaeal dna polymerase and 67 μ l distilled water.This mixture carries out 20 PCR circulations.The 3rd the PCR product of Huo Deing is by<the 1 step like this〉identical method processing, obtain a fragment (being called the CGH fragment here) at last and contain complete CGH gene or total length CGH gene, be dissolved in too in the 20 μ l TE damping fluids.The segmental all processes of preparation CGH illustrates in Fig. 2.
Embodiment 2: preparation of expression vectors
(2-A): the segmental preparation of CGH-N/L, PL and PN
The CGH fragment that about 2 μ g obtain in embodiment 1 uses restriction endonuclease Nde I (10 unit) in 37 ℃ of digestion in 50 μ l 10X NEB reaction buffers 4, carries out phenol extracting and ethanol sedimentation afterwards.The throw out that contains nucleic acid is dissolved in further uses restriction enzyme Sal I (10 unit) to handle 2 hours at 37 ℃ in the 5 μ l 10X NEB reaction buffers 3.
On the other hand, 2 μ g are with intestinal bacteria W3110(KFCC-10667) isolated plasmid ptrp322H-HGH mode same as described above restriction endonuclease Pst I and the digestion of Sal I, other 2 μ g plasmid ptrp322H-HGH digest with restriction endonuclease Pst I and Nde I.Postdigestive plasmid all on 0.7% sepharose electrophoresis isolate 0.6Kb, 1.5Kb and 0.8Kb fragment, respectively called after CGH-N/L fragment, PL fragment and PN fragment.
(2-B): CGH-N/L, PL is connected with PN is segmental
Give about 100ng CGH-N/L fragment, approximately add the T of 2 μ l 10X ligase enzyme damping fluids and 10 units in 100ng PL fragment and the about segmental mixed solution of 100ng PN
4Dna ligase; Then, it is 20 μ l that adding distil water is adjusted to cumulative volume, and this mixture solution was reacted 12 hours at 16 ℃.After finishing this reaction, with reaction mixture transformed into escherichia coli HB 101(ATCC 33694); Filter out the intestinal bacteria bacterium colony that transforms with the ptrp-CST that contains the CGH gene fragment.From transform thalline, isolate plasmid ptrp-CST, use primer 2 090(5 '-CATCACCGAAACGCGCGAG-3 ' again) and primer ptrpl(5 '-GACAATTAATCATCGAACTA-3 ') ptrp-CST is carried out dideoxy dna sequential analysis (Sanger, F.et al, P.N.A.S.74,5463(1977)) to determine the nucleotide sequence of total length CGH gene.
Embodiment 3: with expression vector transformed into escherichia coli and expression CGH gene
The ptrp-CST plasmid transformation escherichia coli W3110(ATCC 27325 that obtains in embodiment 2), the method for use is identical with the method for reference example 4; Transformed bacteria 37 ℃ of concussions in the LB substratum that contains 50 μ g/ml penbritins (every liter contains 10g Bacto-Tryptones (Bacto-triptone), 15g yeast extract, 5g sodium-chlor) were cultivated 12 hours.Getting the 5ml nutrient solution is transferred to 11 capacity and is 5 liters and contains 1L40 μ g/ml penbritin M
9Substratum (40mM K
2HPO
4), 22mM KH
2PO
4, 8.5mM NaCl, 18.7mM NH
4Cl, 1% glucose, 0.1mM MgSO
4, 0.1mM CaCl
2, 0.4% casamino acids, 10 μ g/ml vitamins Bs
1) under 37 ℃, swing in the culturing bottle and cultivated 3-4 hour.When the optical density value (O.D.) of culture reaches 0.5 at 650nm place in each is cultivated, add with the indole acrylic acid (IAA) of various concentration and to make CGH genetic expression (IAA makes IAA concentration in the nutrient solution from 0mM to 1.0mM with the concentration of each 0.1mM of raising).After adding IAA5 hour (do not add IAA, can increase incubation time), with whizzer (Beckman J to 12-24 hour
6-B, rotary head JS 4.2) the centrifugal culture of 3000rpm is 25 minutes, obtains the Bacillus coli cells throw out.The cell precipitation thing is suspended in the sample buffer, presses Laemmli method (Laemmli, Nature 227,680(1970)) and carry out electrophoresis to determine this expression of gene on 12% polyacrylamide gel, the result is referring to Fig. 4.
The the 1st and the 4th capable having shown do not contain CGH gene Bacillus coli cells sample protein matter gel pattern among Fig. 4; The 2nd and 3 behaviors contain CGH gene intestinal bacteria and cultivate cell sample protein gel collection of illustrative plates after 12-24 hour when not adding IAA, and the 5th line display is cultivated when adding IAA concentration reaches 0.1mM and contained CGH gene intestinal bacteria 5 hour cell sample protein matter gel patterns.
As seen in fig. 4, can find that CGH albumen band spectrum clearly can occur on the 2nd, 3 and 5 row 22Kd positions, expression amount accounts for 30% of whole coli somatic protein content at least.
Embodiment 4: the CGH purifying that intestinal bacteria are produced
(4-A): separation of C GH inclusion body from culture of Escherichia coli
(50mM Tris, 50mM EDTA pH7.4), use Polytron agitator (Lightnin, Model TS 1515) to stir 3 minutes then to give 4 liters of damping fluids of adding in 1 kilogram of culture of Escherichia coli.This liquid was handled 3 minutes with ultrasonic generator (Cole-Pamer, Model 4720), added 0.4g N,O-Diacetylmuramidase (these product are from the egg white part) again and make that concentration reaches 0.1g/L in solution, 37 ℃ of stirrings are 30 minutes then.
Add 200ml 20% triton x-100 in this solution, about 5 minutes of vigorous stirring is used centrifugal 30 minutes of whizzer (Beckman JM-21), supernatant discarded, collecting precipitation.(100mM NaCl, 10mM Tris pH7.2) wash throw out, and centrifugation goes out the CGH inclusion body again with 2 liters of damping fluids.
(4-B): the dissolving of CGH inclusion body
The CGH inclusion body that obtains in above-mentioned (4-A) is suspended in 8 liters of distilled water; In it, add 1N NaOH solution then in batches and make pH reach about 12.3, further stirred 3 hours, the last centrifugal insoluble impurities of removing.
(4-C): ultrafiltration and anion-exchange chromatography
Obtaining 8 in above-mentioned (4-B), to go up clear liquid be 3 * 10 with the molecular cut-off size
5Filter membrane carry out ultrafiltration, be concentrated into 1 liter of residual solution.It is 3 * 10 to obtain about 40 liters of molecular weight that this process repeats 4-5 time
5Or be lower than 3 * 10
5Filtrate, this filtrate is 1 * 10 with molecular weight current-carrying size again
4Filter membrane be concentrated into below 20 liters or 20 liters, transfer pH to 9.0 with 1N HCl solution.The concentrated solution that contains CGH is splined on the DEAE-Sepharose chromatography column.This post uses 10mM glycine buffer (pH 9.0) balance to wash post in advance, about 10 liters/hour of elution flow rate, wash 5 column volume 10mM glycine buffers after, use the glycine buffer wash-out that contains 90mM NaCl again instead.The elutriant of Huo Deing (pH 9.0) is 1 * 10 with molecular weight current-carrying size like this
4Or be lower than 1 * 10
4The filter membrane ultrafiltration and concentration be 99.7% to obtain about 3.6g 93% pure monomer CGH(purity), endotoxin content is 10 unit/milligrams or is lower than this value.
Fig. 5 shows the SDS-PAGE result who expresses CGH intestinal bacteria transformant cell extract and purifying CGH.
In Fig. 5, A behavioral standard molecular weight of albumen marker protein; CGH intestinal bacteria transformant whole-cell protein is not expressed in the B behavior; CGH intestinal bacteria transformant whole-cell protein is expressed in the C behavior; D behavior purifying CGH shows as one and is about the 23.5Kd band clearly.
Purifying CGH further uses efficient liquid phase chromatographic analysis, and the result shows that purity reaches 99.7%, and the result of HPLC is in Fig. 6 and table 1.
Table 1
Peak number order 123 amounts to
Retention time 4.656 9.278 11.284
The component ripple
Concentration (ng/ml) 0.0000 0.0000 0.0000 0.0000
Complanation concentration 0.0000 0.0000 0.0000 0.0000
Peak area 0.05533 124.30640 0.32342 124.68514
Peak height 0.00038 0.18592 0.00157 0.18787
Matrix sign indicating number BCB BCB BCB
Reply coefficient 0.0000 0.0000 0.0000 0.0000
Relative retention time 0.0000 0.0000 0.0000 0.0000
Peak area percentage value 0.044 99.697 0.259 100.000
Peak height percentage value 0.205 98.959 0.836 100.000
Though the present invention has obtained describing by above-mentioned specific embodiment, also should be realized that the person skilled in the art also can do various obviously relevant with the present invention operational technology and change and variation simultaneously.These changes and change and also to belong to category of the present invention, will be in the claims in addition clear and definite.
Claims (11)
2, the expression vector that contains chicken growth hormone gene in the claim 1, wherein chicken growth hormone gene is placed on the position that can express on Bacillus coli cells.
3, as the expression vector in the claim 2, it is ptrp-CST.
4, the Bacillus coli cells that transforms with the expression vector described in the claim 2.
5, as the Bacillus coli cells in the claim 4, it is to use ptrp-CST(KCCM-10005) the intestinal bacteria W3110 that transforms.
6, a kind of method of producing chicken growth hormone comprises and cultivating as the intestinal bacteria in claim 4 or 5.
7, a kind of method of purifying chicken growth hormone comprises:
The separatin non-soluble CGH inclusion body of under the condition that is fit to CGH genetic expression, cultivating the intestinal bacteria transformant described in claim 4;
Wash inclusion body with the solution that contains tensio-active agent and ethylenediamine tetraacetic acid (EDTA), then, again with containing NaCl or NH
4The damping fluid of Cl or distilled water clean;
In pH value scope is that the suspend inclusion body washed of 11.5 to 13.0 basic solution is collected at dissolving and forgives intravital CGH;
Centrifugal this suspension is to obtain supernatant liquor;
Supernatant liquor is carried out uf processing to obtain to contain the filtrate of dissolved chicken growth hormone;
With this filtrate by anion exchange resin layer being analysed post to obtain the chicken growth hormone of purifying.
8, method as claimed in claim 7, wherein said tensio-active agent are 0.1 to 1% triton x-100 (Triton X-100) for the final concentration scope.
9, method as claimed in claim 7, wherein said ultrafiltration are meant with a kind of ultra-filtration membrane carries out, this film only allow molecular weight be 3 * 105 or the material that is lower than this value pass through.
10, method as claimed in claim 7, wherein said anionite-exchange resin are the DEAE(diethylaminoethyl-) resin.
11, method as claimed in claim 7, wherein said anion-exchange chromatography have used 70-150mM NaCl solution as elutriant.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR927899 | 1992-05-09 | ||
KR7899/92 | 1992-05-09 | ||
KR1019920007899A KR100229420B1 (en) | 1992-05-09 | 1992-05-09 | Method of purification of chicken growth hormone expressed in e.coli |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1079002A true CN1079002A (en) | 1993-12-01 |
CN1072720C CN1072720C (en) | 2001-10-10 |
Family
ID=19332914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93102099A Expired - Fee Related CN1072720C (en) | 1992-05-09 | 1993-03-05 | Chicken growth hormone gene and an expression thereof in E.coli |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100229420B1 (en) |
CN (1) | CN1072720C (en) |
TW (1) | TW367364B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105695500A (en) * | 2016-02-19 | 2016-06-22 | 常熟理工学院 | Expression and purification method of chicken growth hormone recombinant protein in Pichia pastoris |
CN114891690A (en) * | 2022-06-08 | 2022-08-12 | 山东仙普爱瑞科技股份有限公司 | Complex microbial inoculant with growth promoting performance and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984001150A1 (en) * | 1982-09-16 | 1984-03-29 | Amgen | Avian growth hormones |
CA1267615A (en) * | 1984-08-27 | 1990-04-10 | Dan Hadary | Method for recovering purified growth hormones from genetically engineered microorganisms |
-
1992
- 1992-05-09 KR KR1019920007899A patent/KR100229420B1/en not_active IP Right Cessation
-
1993
- 1993-01-16 TW TW082100273A patent/TW367364B/en active
- 1993-03-05 CN CN93102099A patent/CN1072720C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105695500A (en) * | 2016-02-19 | 2016-06-22 | 常熟理工学院 | Expression and purification method of chicken growth hormone recombinant protein in Pichia pastoris |
CN114891690A (en) * | 2022-06-08 | 2022-08-12 | 山东仙普爱瑞科技股份有限公司 | Complex microbial inoculant with growth promoting performance and application thereof |
CN114891690B (en) * | 2022-06-08 | 2023-09-08 | 山东仙普爱瑞科技股份有限公司 | Composite microbial inoculant with growth promoting performance and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100229420B1 (en) | 1999-11-01 |
TW367364B (en) | 1999-08-21 |
CN1072720C (en) | 2001-10-10 |
KR930023463A (en) | 1993-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1062014C (en) | Recombinant gene coding for human alpha interferon and expression vector thereof, ETC. | |
CN1654656A (en) | FenneropenaeusChinensis Crustin gene and coded protein and cloning method therefor | |
CN1166859A (en) | DNA encoding the-i(bacillus licheniformis) PWD-1 keratinase | |
CN1064079C (en) | A transformant capable of producing d-amino acid oxidase | |
CN1072720C (en) | Chicken growth hormone gene and an expression thereof in E.coli | |
CN1121497C (en) | D-pantolactone hydrolase and gene encoding the same | |
CN106632685A (en) | Amphiphilic peptide-lipase conjugates with increased lipase activity and uses thereof | |
CN1177055C (en) | Antibacterial peptide gene of fly and its cloning process | |
CN100344758C (en) | Antibacterial peptide gene of Chinese prawn containing single whey acidic protein structure domain and its coded antibacterial peptide and application | |
Tragut et al. | Characterization of DNA restriction-modification systems in Spirulina platensis strain pacifica | |
CN1171998C (en) | Antibacterial peptide gene of Chinese prawn and its colon technique | |
CN1181199C (en) | Lichenized bacillus L-25 keratinase and its encoding DNA | |
CN1740320A (en) | Fenneropenaeus chinensis Anti-LPS factor gene and cloning process thereof | |
CN1264983C (en) | Heat-resistant phytase, clone and expression of gene | |
CN1236059C (en) | Grouper insulin-like growth factor II gene, carrier and recombinant strain containing the gene and application thereof | |
CN1300310C (en) | Low temperature lipase and its coding gene and production method | |
CN1597965A (en) | Man's serum albumin with man's parathormone (1-34) fusion protein and its application | |
CN1557960A (en) | Method for separating antibiotic peptide and separated antibiotic peptide | |
CN1157477C (en) | Engineering fungus containing large-scale salmon growth factor | |
CN109762834A (en) | It is a kind of obtain aromatic series prenyltransferase fermentation and a step purifying method | |
CN1164749C (en) | Cattle enteropeptidase catalyzing subunit gene and its gene engineering production process | |
CN1246147A (en) | Enzymatic process for preparation of cephalosporanic 7 beta-(4-carboxybutanamide) acid by means of modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli | |
CN1178835A (en) | Hear resisting basic phosphatase and its expression | |
CN1219588A (en) | New catalase, its gene and composite containing it, and its preparation method | |
CN1437651A (en) | Novel(R)-2-hydroxy-3-phenylpropionate (D-phenyllactate) dehydrogenase and gene encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |